Editorial: implications and future perspectives of the increase in biologics use in paediatric inflammatory bowel disease

Stephanie A. Vuijk, Lissy de Ridder*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1619-1620
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume56
Issue number11-12
DOIs
Publication statusPublished - Dec 2022

Bibliographical note

ACKNOWLEDGEMENT
Declaration of personal interests: S.A. Vuijk: TISKids study wassupported by ZonMw, Crocokids and an Investigator-Sponsored
Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer.

Cite this